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Abstract
One of the most amazing features of the brain is its plasticity. This is a fundamental process 
by which the brain acquires information and makes the appropriate adaptive changes, a 
process that makes us able to think, feel, and remember. Synaptic plasticity refers to the 
ability of connections between neurons, the synapses, to change in strength following activity. 
Dysfunctional synaptic plasticity is recognized as a key factor in several neurological and 
psychiatric disorders, including major depressive disorder. The consolidation of long-term 
changes in synaptic connectivity typically requires gene expression and protein synthesis.  
Recent work shows that post-transcriptional regulation of mRNA translation is critical for 
consolidation of synaptic plasticity and long-term memory. The secretory peptide, brain-
derived neurotrophic factor (BDNF) has been identified as a possible common mediator of 
translational regulation and synaptic plasticity. However, the role of post-transcriptional 
mechanisms in stress and depression are little understood. 
This thesis examines post-transcriptional regulation by BDNF during synaptic 
plasticity, and how translation is regulated in response to antidepressant treatment and stress.  
First we examined the effects of BDNF on translational regulation when BDNF was 
infused into the dentate gyrus in vivo, and following directly application to isolated synapses 
in vitro (synaptodendrosomes). The results indicate a compartment-specific regulation of 
translation in the dentate gyrus in response to BDNF. In synaptodendrosomes, BDNF rapidly 
enhances phosphorylation of the eukaryotic initiation factor 4E (eIF4E) and enhances synaptic 
protein expression. In vivo, local infusion of BDNF induces long-term potentiation (BDNF-
LTP) of synaptic transmission at perforant path granule cell synapses, associated with 
phosphorylation of eIF4E and eukaryotic elongation factor 2 (eEF2). BDNF-LTP and changes 
in translation factor phosphorylation state are dependent on activation of the extracellular 
signal-regulated kinase (ERK).  
Next, we examined the effect of systemic treatment with the selective serotonin 
reuptake inhibitor (SSRI) fluoxetine. We show that chronic, but not acute, injections with 
fluoxetine induces region-specific effects on translation factor activity. Interestingly, chronic 
fluoxetine, like BDNF-infusion, increased phosphorylation of eIF4E and eEF2 specifically in 
the dentate gyrus. The RNA-binding protein cytoplasmic polyadenylation element-binding 
protein (CPEB), which regulates translation of specific mRNAs, was hyperphosphorylated in 
the prefrontal cortex and hippocampus proper following chronic fluoxetine treatment. This 
effect was sustained in the hippocampus proper up to one week after cessation of treatment. In 
addition, chronic fluoxetine induced brain region-specific expression of two atypical CPEB 
isoforms, CPEB3 and CPEB4. Together, these findings support a role for post-transcriptional 
regulation in the delayed action of antidepressant drugs.  
Finally, we examined the effect of chronic mild stress (CMS) as well as acute sleep 
deprivation, a potential antidepressant treatment in humans, on post-transcriptional 
mechanisms of gene expression in the prefrontal cortex, hippocampus proper and dentate 
gyrus. Groups of rats received either: 1) ordinary daily care, 2) 4 weeks of chronic mild stress, 
3) a single 8 hour session of total sleep deprivation, or 4) four weeks of CMS followed by 
sleep deprivation. The results demonstrate region-specific post-transcriptional regulation in 
response to CMS and sleep deprivation. In the dentate gyrus and hippocampus proper, eIF4E 
and eEF2 phosphorylation were selectively modulated by SD, indicating a suppression of 
general protein synthesis in these structures. In the prefrontal cortex, phosphorylation of 
eIF4E is enhanced following both CMS and sleep deprivation, indicating enhancement of 
translational initiation and protein synthesis. These regional differences were further 
supported by differential regulation of genes (Arc and BDNF) previously coupled to synaptic 
plasticity and antidepressant responses.  
We conclude that post-transcriptional regulation is affected not only during BDNF-
LTP, but also in a brain region-specific manner following stress and antidepressant treatment. 
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1 Introduction
1.1 Synaptic plasticity 
In 1894, the neuroanatomist Ramón y Cajal proposed that memory is stored as an anatomical 
change in the strength of neuronal connections. The idea was incorporated into a formal 
hypothesis for learning and memory processing by Donald Hebb in 1949. He proposed that 
cells may grow new connections or undergo metabolic changes that enhance their ability to 
communicate (Hebb’s postulate). Their theories were solely based on theoretical ground. 
However, later experimental investigations proved they were right, and today it is widely 
accepted that neurons can undergo lasting changes. The connection between neurons, the 
synapse, is the most fundamental unit for information transmission in the nervous system. 
Synaptic plasticity refers to the ability of synaptic connections to change in strength following 
activity. Long-lasting changes in synaptic plasticity is considered to underlie learning and 
long-term memory (Malenka and Nicoll, 1999). Much work in the field of neuroscience has 
focused on understanding the molecular mechanisms regulating synaptic plasticity.  
 
 
1.1.1 Long-term potentiation (LTP)
Although conceptualized by Hebb in the 1940s, it was not until the 1970s the first 
publications appeared that clearly demonstrated that synapses could sustain long-lasting 
changes in synaptic efficacy. It was then reported that high.-frequency stimulation of afferent 
fibers of the perforant path in the hippocampus could induce a long-lasting increase in 
synaptic strength, a phenomenon which was termed long-term potentiation (LTP) (Bliss and 
Lomo, 1973). Together with long-term depression (LTD), which refers to long-lasting 
decrease in synaptic strength, these are the most studied forms of long lasting synaptic 
plasticity in mammals (Malenka and Bear, 2004). 
Most of the work on LTP and LTD has been performed in the hippocampal formation, 
a bilateral cortical structure, located in the medial temporal lobe. The hippocampal formation 
belongs to the limbic system, and is required for different forms of memory (Squire et al., 
2004). On the basis of structural differences, the hippocampal formation can be divided into 
the dentate gyrus (DG), the hippocampus proper (Cornu Ammonis fields 1-3 or CA1-CA3) 
and the subiculum (Amaral and Witter, 1989) (Figure1). 
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Figure 1 The hippocampal dentate gyrus (DG) receives the major afferent input from the entorhinal cortex (EC) 
via the perforant path. The granule cells of the dentate gyrus in turn send their axons (the mossy fibers) to 
innervate the CA3 region. The pyramidal neurons of theCA3 region project via the Schaffer collaterals to the 
CA1 pyramidal neurons. The principal output of the hippocampus finally forms the connection of the CA1 to the 
subiculum (Sb) and on to the entorhinal cortex (From Morris and Johnston, 1995). 
 
 
LTP has been the object of intense investigations over the last three decades, as it is believed 
to provide an important key to understand some of the cellular and molecular mechanisms 
that underlies memory formation (Pastalkova et al., 2006; Whitlock et al., 2006). LTP seems 
to be an appropriate cellular model for memory as there is good agreement between results 
from LTP experiments and memory tests (Lynch, 2004).  
Induction of LTP is mediated by activation of the excitatory neurotransmitter 
glutamate and regulation of intracellular signalling cascades. Glutamate, which is the major 
excitatory neurotransmitter in the brain, causes neuronal depolarization via activation of 
postsynaptic -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors that 
increase intracellular Na+. This leads to the subsequent activation of N-methyl-D-aspartate 
(NMDA) receptors and results in influx of Ca2+ through the receptor channel. Similar to 
memory, LTP can be divided into two distinct phases which involves different molecular 
mechanisms; early phase LTP (E-LTP), which lasts only minutes to few hours, and late phase 
LTP (L-LTP), which can persist for many hours, days or months . E-LTP, like short-term 
memory, does not require new gene expression, but requires modification of pre-existing 
proteins. This is typically phosphorylation of protein kinases that are sensitive to the increase 
in intracellular Ca2+, like - Ca2+/ calmodulin-dependent protein kinase II (-CaMKII) and 
protein kinase C (PKC). L-LTP, like long-term memory, requires new gene transcription and 
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protein synthesis (Davis and Squire, 1984; Bliss and Collingridge, 1993; Nguyen et al., 1994; 
Kandel, 2001). Activation of protein kinases is a crucial event in signal transduction leading 
to gene transcription. -CaMKII, PKC, protein kinase A (PKA), and extracellular signal-
related protein kinase (ERK) have been suggested to have important roles in LTP (Soderling 
and Derkach, 2000; Sweatt, 2001; Rosenblum et al., 2002). When ERK is activated it can 
translocate to the nucleus where it activates the transcription factor cAMP-response-element 
binding protein (CREB) and transcription of immediate early genes (IEGs) (Patterson et al. 
2001; Rosenblum et al. 2002). One of the IEGs is Arc, which encodes an mRNA that rapidly 
transports to dendrites of dentate granule cells and accumulates near stimulated synapses 
where it is translated locally (Lyford et al. 1995; Link et al. 1996; Steward et al. 1998; 
Steward and Worley, 2001; Rodriguez et al. 2005). L-LTP is expressed through several 
morphological and molecular changes of the synapse. Dendritic spines, which are the primary 
recipients of excitatory input, can undergo rapid changes. This can include altered shape or 
enlargement of spines, increased number of AMPA receptors in the spines, as well as 
formation of new spines (Isaac et al., 1995; Liao et al., 1995; Toni et al., 1999; Bourne and 
Harris, 2008). Dendritic spines provide a local biochemical compartment where ions and 
signalling molecules become concentrated following synaptic activation. The process of spine 
enlargement is dependent on sustained synthesis of Arc protein (Bramham et al., 2010). 
Another protein critically involved in LTP, and which can activate Arc-dependent LTP 
consolidation, is brain-derived neurotrophic factor (BDNF). 
 
 
1.1.2 BDNF
The neurotrophin family consists of secretory peptides that were originally identified as 
promoters of neuronal survival. The mammalian neurotrophins consist of nerve growth factor 
(NGF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4) and brain-derived neurotrophic factor 
(BDNF) (Lewin and Barde, 1996). Each of them activate one or more of the three members of 
the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB and 
TrkC), while all of them activate the p75 neurotrophin receptor (p75NTR), a member of the 
tumour necrosis factor receptor superfamily. In addition to promote survival, the 
neurotrophins also have important roles in development and differentiation of the nervous 
system (Ernfors, 2001). BDNF, which  is the most abundant neurotrophin in the mammalian 
brain (Murer et al., 2001), has received a lot of attention because of its critical role in synaptic 
 9
plasticity (Bramham and Messaoudi, 2005). BDNF is widely distributed in the mammalian 
brain, with the highest expression levels in the hippocampus, neocortex, amygdala, 
cerebellum, septum, and several hypothalamic nuclei (Ernfors et al., 1990; Hofer et al., 1990; 
Phillips et al., 1990; Dugich-Djordjevic et al., 1995; Castren et al., 1995). BDNF binds the 
TrkB receptor with high affinity to induce its dimerization and autophosphorylation of 
tyrosine residues in the cytoplasmic kinase domain. When phosphorylated, these residues 
serve as docking sites for scaffolds/adaptor proteins that are coupled to three main signalling 
pathways: the extracellular signal-regulated protein kinase (ERK)-, the phospholipase C-§
(PLC-§and the phosphatidylinositol-3-kinase (PI3K) pathways (Kaplan and Miller, 
2000; Reichardt, 2006). By activating these signalling pathways, BDNF regulate gene 
expression, through modulation of transcription factors (Finkbeiner et al., 1997) and 
translation factors (Soule et al., 2006). 
Signalling through the ERK pathway is critical for activation of the transcription factor 
CREB (Shaywitz and Greenberg, 1999; Adams et al., 2000). ERK also plays a critical role in 
protein synthesis dependent plasticity by increasing phosphorylation of eIF4E (Klann and 
Dever, 2004; Kelleher, III et al., 2004). Activation of the PLC-§pathway leads to an 
increase of intracellular Ca2+, and activation of Ca2+-sensitive kinases likeCaMKII. The 
activity-induced expression of BDNF has also been shown to depend on Ca2+-influx and 
CaMKII activation (Du et al., 2000). The PI3K pathway activates translation via a cascade 
driving the mammalian target of rapamycin (mTOR), a major regulator of protein synthesis 
(Sarbassov et al., 2005). BDNF stimulates translation through activation of mammalian target 
of rapamycin (mTOR) in this pathway (Schratt et al., 2004). The PI3K pathway also regulates 
the trafficking of synaptic proteins (Yoshii and Constantine-Paton, 2007).  
BDNF is critically involved in LTP. First of all, induction of LTP induces expression 
of BDNF mRNA in the hippocampus (Castren et al., 1993; Bramham et al., 1996). Release of 
BDNF has been shown to be activity-dependent (Goodman et al., 1996; Canossa et al., 1997; 
Hartmann et al., 2001; Aicardi et al., 2004), and activity-dependent release of BDNF plays a 
critical role in LTP (Bramham and Messaoudi, 2005). Studies with transgenic mice have 
shown that LTP is impaired in mice lacking BDNF, but that this impairment is reversed when 
BDNF is re-expressed (Korte et al., 1995;Korte et al., 1996). In addition, a weak synaptic 
activation, below the LTP threshold, induces LTP when BDNF is simultaneously applied 
(Figurov et al., 1996; Kovalchuk et al., 2002). It is thought that the potentiating effect of 
BDNF on E-LTP is achieved, at least in part, by enhancing synaptic responses to high 
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frequency stimulation and by presynaptically facilitating synaptic vesicle docking (Pozzo-
Miller et al., 1999; Jovanovic et al., 2000; Tyler and Pozzo-Miller, 2001). Moreover, 
exogenously applied BDNF to hippocampal slices can induce a long-lasting increase in 
synaptic efficacy in the CA1 region (Kang and Schuman, 1995). Also, BDNF infusion into 
the dentate gyrus of intact rats induces a long-lasting potentiation (Messaoudi et al., 1998), an 
effect termed BDNF-LTP. It has been suggested that BDNF is necessary for, and can directly 
activate the transcription- and translation dependent late phase of LTP (Korte et al., 1998; 
Gartner and Staiger, 2002; Messaoudi et al., 2002; Barco et al., 2005). BDNF-LTP is 
dependent on activation of the ERK pathway, and increased transcription and translation of 
activity-regulated cytoskeletal-associated protein (Arc) (Ying et al., 2002; Messaoudi et al., 
2007). A microarray study has identified nine genes that are strongly upregulated with Arc 
during BDNF-LTP and LTP induced by high-frequency stimulation (HFS-LTP), in the 
dentate gyrus (Wibrand et al., 2006).  
 
 
1.1.3 Dendritic protein synthesis 
As mentioned, long-lasting forms of synaptic plasticity and memory are dependent on 
synthesis of new proteins. The classical view is that proteins are synthesized in the cell body 
and delivered to potentiated synapses. The possibility that proteins could be synthesized at 
other sites then in the cell body was first suggested by the observations of mRNAs and 
polyribosomes in dendrites (Bodian, 1965; Steward and Levy, 1982). Since this discovery, 
several studies have shown that dendritic protein plays a key role in synaptic plasticity (Sutton 
and Schuman, 2006). Dendritic protein synthesis enables synapses to control synaptic strength 
independent of the cell body via rapid protein production from pre-existing mRNA. It also 
enables specificity in that proteins are made available only at the stimulated synapses, which 
is where new proteins are required. 
Many mRNAs have been found to be localized to dendrites (Crino and Eberwine, 
1996; Steward and Schuman, 2001; Zhong et al., 2006). Some of these have been shown to be 
locally translated in response to extracellular stimulation, e.g. -CaMKII (Ouyang et al., 1997; 
Ouyang et al., 1999; Scheetz et al., 2000), Arc (Steward et al., 1998), and  CREB (Crino et al., 
1998). However, little is known about the mechanisms that regulate translation in dendrites, 
and causal roles for specific dendritically synthesized proteins in stable forms of synaptic 
plasticity have not been clearly defined.  
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Several studies have demonstrated that BDNF can regulate the local synthesis of 
synaptic proteins (Kang and Schuman, 1996; Huber et al., 2000; Aakalu et al., 2001; Zhang 
and Poo, 2002; Yin et al., 2002).  
 
 
1.2 Translational regulation
Regulation of gene expression at the level of mRNA translation plays a key role in regulation 
of long-lasting synaptic changes. Translational regulation may effectively dictate the time, 
place, and amount of protein synthesis in order to meet the dynamics demands of the active 
neuron.  
Translational regulatory mechanisms fall into two categories: general mechanisms, 
which apply to translation of many or all mRNAs, and mRNA-specific mechanisms, which 
apply to the translation of a particular subset of mRNAs based on recognition of RNA binding 
proteins or miRNA to specific sequences in the target mRNA. Neurons employ both general 
and mRNA specific translation in the context of long-term synaptic plasticity.  
Translation is generally divided into three steps: initiation, elongation, and termination. 
Initiation involves recruitment of mRNA and tRNAiMet to a ribosome. During elongation, 
aminoacyl-tRNAs are sequentially recruited and the peptid-chain lengthens incrementally as 
amino acids are covalently attached via peptide bonds. Finally, the polypeptide chain is 
released from the ribosome. Each step is regulated by several translation factors; eukaryotic 
initiation factors (eIF), eukaryotic elongation factors (eEF) and eukaryotic release factors 
(eRF). In eukaryotic cells, initiation is usually the rate-limiting step in the translation process, 
and therefore also a primary target for regulation (Gingras et al., 1999). However, translation 
may also be regulated at the elongation step (Browne and Proud, 2002). Regulation of the 
activity of translation factors by phosphorylation appears to be a general mechanism for the 
regulation of general protein synthesis.  
 
In this thesis, I have focused on general mechanisms of translational regulation, mediated by 
two key translation factors, eIF4E and eEF2, as well as mRNA-specific mechanisms, 
mediated by CPEB1, which binds to and regulate the translation of specific mRNAs. 
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1.2.1 The role of eIF4E in translation initiation 
Translation initiation can be subdivided into three steps: 1) formation of the 43S ribosomal 
preinitiation complex, 2) binding of the mRNA to the 43S ribosomal complex, and 3) 
formation of the 80S ribosomal complex (Figure 2). 
Recruitment of the ribosome to the mRNA usually occurs by a cap-dependent 
mechanism, in which ribosome binding is facilitated by the 7-methylguanosine 5-triphosphate 
cap structure (m7GpppX) in the 5' end of the mRNA. eIF4E binds with high affinity to the 5'- 
mRNA cap structure and forms the eIF4F complex (Matsuo et al., 1997). In addition to eIF4E, 
the eIF4F complex also contains a RNA scaffolding protein (eIF4G) and eIF4A that functions 
to identify and unwind the mRNA for subsequent 43S ribosome association (Gingras et al., 
1999). In addition to binding eIF4E and eIF4A, eIF4G also binds the translation factor eIF3 
and the poly(A)- binding protein (PABP), which binds to the poly(A) tail on the 3'-end of the 
mRNA (Sonenberg and Dever, 2003). eIF4E may also mediate 5' mRNA interactions with its 
3'-terminus which result in circular mRNA conformations with altered rates of translation 
(Stebbins-Boaz et al., 1999; Cao and Richter, 2002). Binding of eIF4E to the 5'-mRNA cap 
can be regulated by proteins that bind to and sequester eIF4E and prevents eIF4E from 
binding to eIF4G, or by phosphorylation of eIF4E.  
The eIF4E-binding proteins (4E-BPs) are regulated by phosphorylation as well; when 
4E-BP is phosphorylated, its binding to eIF4E is inhibited so that eIF4E is free to bind the cap 
and eIF4G and initiate translation (Gingras et al., 1999). Several protein kinases have been 
shown to phosphorylate 4E-BP, including mammalian target of rapamycin (mTOR), whose 
activity is blocked by rapamycin (Beretta et al. 1996), and the mitogen-activated protein 
kinases ERK1 and ERK2 (Lin et al. 1994).  
Binding of eIF4E to the 5'-mRNA cap can also be regulated via phosphorylation of 
eIF4E itself. Mammalian eIF4E is phosphorylated on a single residue, Ser209, by the 
mitogen-activated protein kinase-interacting kinase 1 (Mnk1) (Wang et al., 1998; Waskiewicz 
et al., 1999). Mnk1 is phosphorylated and activated by the mitogen-activated protein kinases 
ERK and p38 (Waskiewicz et al., 1997), kinases that are known to be critical for various 
forms of synaptic plasticity (Bolshakov et al., 2000; Sweatt, 2001; Thiels and Klann, 2001; 
Gallagher et al., 2004). Several studies have demonstrated that eIF4E phosphorylation is 
positively correlated with enhanced translation of mRNA (Scheper and Proud, 2002; Senthil 
et al., 2002; Duncan et al., 2003; Gingras et al., 2004). It has been indicated that 
phosphorylation of eIF4E reduces its cap-binding affinity (Scheper and Proud, 2002; Zuberek 
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et al., 2003) and that this reduced affinity for the cap structure results in release of eIF4E, 
permitting reinitiation on the same mRNA or on another message (Scheper and Proud, 2002), 
thereby resulting in increased translation activity. Phosphorylation of both 4E-BP and eIF4E 
are increased by ERK activation in the hippocampus, thereby synaptic activity that activates 
the ERK pathway can stimulate translation initiation (Kelleher et al. 2004; Banko et al. 2005). 
Enhanced phosphorylation of Mnk1 and eIF4E has been shown to occur in cultured 
neurons treated with BDNF, and the increased eIF4E phosphorylation was shown to be ERK 
dependent (Takei et al. 2001; Kelleher III et al. 2004). It has also been shown that NMDA 
receptor activation enhances the phosphorylation of Mnk1 and eIF4E via ERK in 
hippocampal area CA1 (Banko et al. 2004) and L-LTP-inducing stimulation has been shown 
to result in an ERK-dependent increase in eIF4E phosphorylation (Kelleher III et al. 2004). 
Thus, phosphorylation of eIF4E by Mnk1 via activation of either ERK or p38 is another way 
in which translation initiation is likely to be regulated during synaptic plasticity. BDNF-
induced increase in translation is dependent on both the ERK and PI3K pathways (Takei et al., 
2001; Takei et al., 2004). Activation of eIF4E can be mediated through both the ERK and 
PI3K pathways. Activated ERK phosphorylates its substrate MAP kinase-interacting kinase1 
(Mnk1), which again phosphorylates eIF4E.   
Once the eIF4F complex has bound to the 5'-mRNA cap structure, the 43S ribosomal 
preinitiation complex is recruited to the 5'-end of the mRNA and scans the 5´-UTR until it 
reaches the start codon (AUG). eIF4G is bridging the mRNA to this complex  through 
interactions with eIF3, which is bound to the 40S ribosomal subunit (Gingras et al., 1999). At 
the start codon, the 60S ribosomal subunit joins the 40S subunit to form a translationally 
competent 80S ribosome. The next step is now elongation.  
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Figure 2 Pathway of translation initiation (From Klann and Dever, 2004) 
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1.2.2 The role of eEF2 in translation elongation 
Elongation is the process of adding amino acids to the growing polypeptide chain. One amino 
acid is added at a time, and peptide bonds are formed between the incoming amino acid and 
the growing polypeptide (Figure 3).  
The process of peptide-chain elongation involves recruitment of the amino acyl-
tRNAs to the A-site of the ribosome and translocation, in which the ribosome moves relative 
to the mRNA by the equivalent of one codon. In eukaryotes, the factors involved in amino 
acyl-tRNA recruitment are eEF1A and eEF1B, while translocation requires eEF2. The major 
mechanism for regulating elongation is through phosphorylation of eEF2 (Herbert and proud 
2007). eEF2 is a GTP-binding protein that mediates translocation of peptidyl-tRNA from the 
A-site to the P-site on the ribosome by hydrolyzing GTP (Moldave, 1985). The movement of 
the ribosome along the mRNA is repeated until a stop codon is reached, at which point 
elongation is terminated and the ribosomal subunits are released from the mRNA. 
Phosphorylation of eEF2 at threonine-56 (Thr56) inhibits its activity by preventing it from 
binding to the ribosome, leading to reduced rate of elongation and decreased general 
translation (Ryazanov and Davydova, 1989; Carlberg et al., 1990; Redpath and Proud, 1993). 
However, some mRNAs which are critically involved in long-lasting synaptic plasticity (like 
Arc and -CaMKII), undergo enhanced translation under conditions of eEF2 phosphorylation 
and decreased general translation and (Scheetz et al., 2000; Chotiner et al., 2003; Kelleher, III 
et al., 2004; Belelovsky et al., 2005).  
eEF2 is phosphorylated by eEF2 kinase. This kinase is regulated by Ca2+/calmodulin, 
and thus by neuronal activity (Herbert and Proud, 2007). eEF2 kinase can also be 
phosphorylated by cAMP-dependent protein kinase (PKA), which results in that eEF2 kinase 
becomes partially independent of Ca2+/calmodulin for activity (Redpath and Proud, 1993). 
eEF2 kinase has also been shown to be a substrate for p70 S6 kinase and p90RSK1 (Wang et 
al., 2001). p70 S6 kinase is activated in an mTOR dependent manner, whereas p90RSK1 is 
activated by ERK. The ERK pathway can be activated by a variety of stimuli including 
different agonists, and this signalling connection then potentially allow these different 
agonists to modulate protein synthesis via the ERK pathway (Browne and Proud, 2002).  
 
 
 
 16 
 
 
 
Figure 3 Simplified model for the translation elongation process (From www.nobelprize.org) 
 
1.2.3 The role of CPEB in mRNA-specific translational regulation 
CPEB1 is a member of an evolutionarily conserved family of RNA binding proteins (CPEB1-
4 in vertebrates). CPEB1 targets mRNAs containing one or more cytoplasmic polyadenylation 
elements (CPEs), a U-rich structure in the 3´ UTR (Hake et al., 1998).  
CPEB was first described in Xenopus oocytes (Hake and Richter, 1994) and this is 
also where most of the mechanisms regarding CPEB have been elucidated. In its non-
phosphorylated form, CPEB functions indirectly as a translational repressor. CPEB binds to 
CPE in the target mRNA and inhibits translation initiation. CPEB binds to the protein Maskin, 
which in turn is bound to eIF4E. The binding of Maskin to eIF4E precludes the binding of 
eIF4G to eIF4E, thus inhibiting the formation of the initiation complex (Figure 4). Repressing 
translation may be of importance when CPEB1 is contributing to transport of its targets along 
microtubules, another important function of this protein (Huang et al., 2003).  
Cytoplasmic polyadenylation is a widely used mechanism to activate translation, and 
CPEB1 is the key protein that controls this process. Polyadenylation requires both the CPE 
 17
and a nearby structure, the hexanucleotide sequence (AAUAAA). Phosphorylation of CPEB 
initiates polyadenylation (Mendez et al., 2000), which is the addition of adenine bases (A) to 
extend the poly(A) tail in the 3´end of the mRNA. Extension of the poly(A)- tail length is 
linked to 5´ capping of the mRNA and enhanced translation (Kuge and Richter, 1995); 
phosphorylation causes CPEB to bind and recruit the cleavage and polyadenylation specificity 
factor (CPSF) into an active polyadenylation complex, and helping it to associate with the 
hexanucleotide sequence. CPSF recruits poly(A) polymerase (PAP) to the end of the mRNA, 
were it catalyzes addition of poly(A) (Barnard et al., 2004). The newly elongated poly(A)-tail 
is then bound by poly(A)-binding protein (PABP), which in turn associates with eIF4G. This 
association will displace Maskin, and eIF4G can bind to eIF4E, and initiating translation 
(Stebbins-Boaz et al. 1999; Cao and Richter, 2002). CPEB1 contains two critical residues 
(T171 and S177) which can be phosphorylated by either Aurora A kinase or -CaMKII in 
hippocampal neurons in response to NMDA receptor activation (Huang et al., 2002; Atkins et 
al., 2004). 
CPEB1 is present in many regions of the brain, most abundantly in the hippocampus 
and cerebral cortex, were it localizes to synapses and particular the postsynaptic density (Wu 
et al., 1998). At synapses, many of the factors involved in polyadenylation-induced translation 
have been detected (Huang et al. 2002).  
Only a few targets have been shown to undergo polyadenylation-induced translation in 
response to synaptic activity; -CaMKII, tissue plasminogen activator (tPA), MAP2 and 
AMPA receptor binding protein (ABP), (Wu et al., 1998; Huang et al., 2002; Shin et al., 2004; 
Du and Richter, 2005). The identified CPEB target mRNAs encode proteins that have 
important roles in synaptic plasticity (Du and Richter, 2005; Pique et al., 2008). Studies with 
CPEB knock-out mice have also demonstrated that CPEB is important for some forms of 
synaptic plasticity (Alarcon et al., 2004), as well as for extinction of hippocampal-dependent 
memories (Berger-Sweeney et al., 2006).  
The other CPEB isoforms, CPEB2-4, have been shown to constitute a different class 
of RNA binding proteins. Huang and colleagues demonstrated that CPEB2–4 do not interact 
with the CPE, but bind another element in the mRNA. Moreover, CPEB3, unlike CPEB1, 
does not require the hexanucleotide AAUAAA to regulate translation, neither does it bind 
CPSF, indicating that it regulates translation in a polyadenylation-independent manner 
(Huang et al., 2006). CPEB3 and -4 are expressed in only partially overlapping regions of the 
brain, but both are expressed in dendrites and synapses of hippocampal neurons (Huang et al. 
2006). While CPEB3 has been found to repress translation of AMPA receptor GluR2 mRNA 
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in neurons (Huang et al., 2006) and also to be associated with human episodic memory 
(Vogler et al., 2009), a function of CPEB4 has still not been characterized.  
The CPEB family are very attractive proteins considering that CPEB in the sea slug 
Aplysia Californica (ApCPEB) has been shown to have prion-like properties, caused by an N-
terminal domain with high glutamine content and conformational flexibility (Si et al., 2003). 
When in the prion state, CPEB induces other normally shaped CPEB proteins to also enter the 
prion state. Unlike other prion proteins, it is the dominant, self-perpetuating state of the 
protein which is the active form. By having such prion-like properties, CPEB might be able to 
maintain its activity for a long time after stimulation and therefore have an important role in 
maintenance of long-term synaptic plasticity (Shorter and Lindquist, 2005; Si et al., 2010). 
The CPEB3 protein is the most likely candidate for being a functional homologue of the 
ApCPEB as they share some common features, like the glutamine-rich region in the N-
terminal (Theis et al., 2003). 
 
                     
 
 
Figure 4 Regulation of translation initiation by CPEB (from Klann and Dever, 2004) 
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1.3 Depression
Mood disorders are generally classified as either major depressive disorder (MD) or 
bipolar disorder (BD). The focus in this thesis will be major depressive disorder, which is 
termed depression in the following text. Depression is a serious condition that affects both the 
mental and physical health. Up to 20% of the population worldwide is affected, women 
almost twice as often as men (Wong and Licinio, 2001). Based on a survey by the World 
Health Organization depression is one of the top ten causes of morbidity and mortality 
worldwide. Formal classification as depression requires that at least five of the following 
symptoms last for at least two weeks:  
 
 Depressed or irritable mood 
 Decreased interest in pleasurable activities and ability to experience pleasure 
(anhedonia) 
 Significant weight gain or loss (>5% change/month) 
 Sleep disturbance (Insomnia or hypersomnia) 
 Psychomotor agitation or retardation 
 Fatigue or loss of energy 
 Feelings of worthlessness or excessive guilt 
 Diminished ability to think or concentrate 
 Recurrent thoughts of death or suicide 
 
Depressed mood or anhedonia must be one of the symptoms (Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) (American 
Psychiatric Press; 2000). Diagnosing can be complicated as subtypes of depression may differ 
not only in aetiology and clinical picture, but also in clinical response to medical treatments 
(Antonijevic, 2006). It has been indicated that depression subsumes numerous disease states 
of distinct aetiology, and perhaps distinct pathophysiology (Berton and Nestler, 2006).  
Some individuals have a higher genetic risk for being depressed than other. The 
heritability of depression is likely to be in the range of 40-50%. There has been identified a 
number of genetic loci associated with vulnerability to depression or antidepressant efficacy. 
For example, there seem to be an association between combined polymorphisms in the 5-
HT1A and BDNF genes and the risk of treatment-resistant depression (Anttila et al., 2007). 
Genetic predispositions are thought to interact with environmental risk factors for the 
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development of depression. Recent interest in epigenetic regulation of gene expression in the 
brain might lead to new, important information about depression. A review from Tsankova et 
al., 2007 summarizes recent evidence for how epigenetic mechanisms of gene regulation in 
neurons can be implicated in depression (Tsankova et al., 2007). 
Left untreated, depression can be life-threatening due to risk of suicide. Treatment 
usually consists of psychotherapy and/or antidepressant medications, while electroconvulsive 
treatment (ECT) has for a long time been used to treat depression in patients who do not 
respond to other treatments (Paul et al., 1981). Although very effective, the use of ECT can 
result in memory loss and other cognitive deficits (Frasca et al., 2003). The primary medical 
treatment of depression has been through drugs that increase the concentration of biogenic 
monoamines (serotonin, noradrenalin and/or dopamine) in the brain. 
In the 1950s it was discovered that a drug which was prescribed against tuberculosis 
elevated mood in some patients who were depressed. It was then revealed that the drug 
inhibited the neuronal breakdown of monoamines by the enzyme monoamine oxidase, which 
led to the statement of the monoamine hypothesis of depression (Bunney, Jr. and Davis, 1965; 
Schildkraut, 1965). The hypothesis proposes that depression is caused by a deficiency of 
monoamines in the brain, and that targeting this with antidepressants would tend to restore 
normal function in depressed patients (Nestler et al., 2002). Based on this, monoamine 
oxidase inhibitors were developed as the first class of antidepressants. In the late 1980s, 
Prozac (fluoxetine) and other drugs that block serotonin reuptake transporters without 
affecting other monoamines were approved for commercial use. These selecitve serotonin 
reuptake inhibitors (SSRI`s) became known as "novel antidepressants" along with other newer 
drugs such as serotonin-noradrenaline reuptake inhibitors (SNRIs) and noradrenaline reuptake 
inhibitors (NRIs). These, and also newer types of drugs designed to increase monoamine 
levels in the brain, are more efficient and produce less side effects than the older drugs do. 
However, more than half of all depressed individuals do not respond adequately to 
antidepressant drugs, and side-effects are still problematic to many (Trivedi et al., 2006; 
Sonnenberg et al., 2008; Papakostas, 2010). This raises a requirement for new and more 
efficient treatment. After the discovery of the SSRIs in the 1980s, development of newer 
drugs has seen little progress. The reason for this is that still today the precise molecular and 
cellular mechanisms underlying the action of these drugs or depression are not clearly 
understood.  
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1.3.1 The neurobiological basis of depression 
Depression is a complex and highly heterogeneous disorder that is influenced by genetic, 
environmental and neurobiological factors. Despite years of intensive research, the 
neurobiological basis of depression and the mechanisms underlying antidepressant action 
remains poorly understood. Although antidepressant drugs raises the monoamine levels in the 
brain shortly after they are taken, these drugs have to be taken for at least two weeks until a 
therapeutic response appear. This long delay in clinical response indicates that the monoamine 
hypothesis does not provide a complete explanation for the actions of antidepressant drugs or 
for the pathophysiology of depression. The monoamine hypothesis evolved over the years to 
include, for example, adaptive changes in 5-HT receptors to explain the delayed clinical 
response to antidepressant treatment. Still, the monoamine hypothesis does not address key 
issues, like why all drugs that enhance serotonergic or noradrenergic transmission are not 
necessarily effective in depression. Despite the limitations, development of the monoamine 
hypothesis has been of great importance in understanding depression and in the development 
of safe and effective antidepressants (Hirschfeld, 2000).  
The delayed clinical response constitutes a major problem in the treatment of 
depression. A better understanding of how the drugs work and also of the aetiological and 
pathophysiological factors in depression is needed to develop more efficient and faster acting 
treatment. Today, it is becoming more and more evident that certain aspects of depression 
result from maladaptive neuroplastic changes in specific neural circuits (Krishnan and Nestler, 
2008), whereas antidepressants produce secondary changes that are on a longer timescale and 
mediate molecular and cellular plasticity (Nestler et al., 2002; Pittenger and Duman, 2008).  
 
 
1.3.2 Stress and depression
Stress is probably the most important environmental factor that can trigger depression 
in some vulnerable individuals (Kendler et al., 1999; Caspi et al., 2003). Severe stress, either 
physical or psychological, often precedes the first or second episode of depression, but plays a 
minor role in the onset of subsequent episodes. Studies in twins have shown a clear 
interaction between genetic predisposition and a recent stressful life event in the precipitation 
of a depressive episode (Kendler, 1998). Stressful life events in childhood have been shown to 
predispose the individual for development of depression in adulthood (Kendler et al., 1992; 
McCauley et al., 1997; Agid et al., 2000). Individuals who have both a genetic risk of being 
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depressed and a traumatic childhood seem to be unusual prone to developing depression 
(Nemeroff and Vale, 2005).  
The relationship between stress and depression remains to be fully established. The 
reduced neuronal plasticity, which is suggested as an important link, may be explained by 
dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis as well as structural and 
physiological alterations in the hippocampus and prefrontal cortex. At the molecular level, it 
has been suggested that cellular deficiencies in these brain regions may partly result from a 
decrease in the expression BDNF.  
 
 
1.3.2.1 Dysregulation of the HPA axis 
Stress is defined as an event or events that are interpreted as uncontrollable or 
threatening to an individual, and which elicit physiological and behavioural responses. Some 
of these responses are caused by activation of the HPA axis, a feedback loop by which signals 
from the brain trigger the release of hormones needed to respond to the stress. In response to 
stress, the hypothalamus releases corticotropin-releasing hormone (CRH). The CRH in turn 
causes the pituitary gland to release adrenocorticotropic hormone (ACTH) into the 
bloodstream, from which it enters the adrenal glands and causes them to secretre 
glucocorticoids (cortisol in humans, corticosterone in rats). Glucocorticoids also exerts a 
negative feedback effect to shut down the stress response after the threat has passed, acting 
upon the hypothalamus and causing it to stop producing CRH. This stress circuit affects 
systems throughout the body. Under stressful conditions, there is a strong increase in the 
glucocorticoids secretion achieved within 10 to 30 minutes (Paris et al., 1987). 
Glucocorticoids readily enter the brain and their actions are mediated by two receptors, the 
glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). In the rat brain, 
corticosterone binds to mineralocorticoid receptors (MRs) with a 10-fold higher affinity than 
to glucocorticoid receptors (GRs) (Reul and de Kloet, 1985; Reul et al., 1998). As a 
consequence, these MRs are close to saturated under basal resting conditions, while high 
corticosterone concentrations during stress occupy both MRs and GRs (Reul and de Kloet, 
1985). MRs are predominantly localized in limbic brain regions (including the hippocampus) 
while GRs are widely distributed in the brain.  
Glucocorticoids typically have adaptive effects in the short run. Acute, mild stress can 
have a positive effect in turns of enhanced learning and memory (Luine et al., 1996). It is also 
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found that low levels of glucocorticoids  amplify LTP (de Kloet, 2004). Conversely, high 
levels or severe stress impair LTP (Kim and Diamond, 2002; de Kloet, 2004) and enhance 
LTD (Xu et al., 1997) in the hippocampus. 
Prolonged stress may create abnormalities in the HPA axis, which include a 
hypersecretion of glucocorticoids. This is thought to be an important factor in the 
pathogenesis of depression (Holsboer, 2000; Ising et al., 2005). Treatment with SSRI`s 
normalizes the HPA axis, but the mechanisms behind are unknown. When treatment stops, the 
HPA axis abnormalities returns, indicating that treatment have to be continued to avoid 
recurrences of depression (Plotsky et al., 1998). The HPA axis regulates arousal, sleep, 
appetite and the capacity to experience and enjoy pleasure factors that also are known to be 
affected in depression. 
There exist large individual differences in how to cope with stress, and it is expected 
that differences in coping styles reflects differences in individuals vulnerability to stress 
related disorders (Koolhaas et al., 2007). Coping strategies involves behavioural, 
physiological and neurobiological tools that helps to diminish the impact of the stressors. 
Proactive coping is associated with high sympathetic reactivity to stressors whereas the more 
passive or reactive coping style generally has a higher HPA axis reactivity (Koolhaas, 2008). 
. 
 
1.3.2.2 Structural changes in the hippocampus and prefrontal cortex 
The consequences of stress are different in different brain regions, for example are the effects 
in amygdala completely opposite to what is seen in the hippocampus and prefrontal cortex. 
Here, the focus will be on the two latter structures.  
Since the hippocampal formation has the highest expression of GC receptors in the 
brain (de Kloet et al., 1998) it is especially vulnerable to increasing levels of 
glucocorticoids/stress. Several forms of stress lead to atrophy and retraction of apical 
dendrites in the CA3 region (Watanabe et al., 1992; McEwen, 1999), reduced extent of 
neurogenesis in the dentate gyrus (Gould et al., 1997; Gould et al., 1998), and reduced 
complexity of neuronal processes in the hippocampus (Alfarez et al., 2009). Since the 
hippocampus has afferents to, and regulates the function of, the prefrontal cortex, reduced 
hippocampal function could also have consequences for the prefrontal cortex. The 
hippocampus also innervates and regulates the nucleus accumbens and ventral tegmental area 
(VTA), and impaired hippocampal function might contribute to the symptoms of anhedonia  
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(Warner-Schmidt and Duman, 2006), since the nucleus accumbens is involved in the 
mechanisms of natural reward (Nestler and Carlezon, Jr., 2006). The hippocampus also has 
projections to the hypothalamus, and another important function of the hippocampus is its 
negative modulation of the HPA axis. Hippocampal dysfunction is thought to contribute to the 
dysfunction of the stress response that is seen in depression. 
Chronic stress leads to regression of the apical dendrites of pyramidal cells in the 
medial prefrontal cortex of rats (Cook and Wellman, 2004). Chronic stress (Banasr et al., 
2007) or exposure to glucocorticoids (Alonso, 2000) also results in a reduction in the 
proliferation of glia in the PFC. A reduction in the number of glia is also observed in 
depressed patients (Ongur et al., 1998; Rajkowska, 2000). Loss of glia is expected to have 
negative impact on the neuronal plasticity, as glia provides metabolic support for the neurons, 
in addition to having an important role in the synthesis and inactivation of glutamate. Stress 
and glucocorticoids lead to elevations in extracellular glutamate concentrations in the 
hippocampus and prefrontal cortex, which may contribute to the deleterious effects of stress 
in these brain regions (Lowy et al., 1993; Sapolsky, 2000). 
Hippocampal volume has been found to be decreased after chronic stress in rats (Lee
et al. 2009), as well as in depressed humans (Sheline et al., 1996; Campbell et al., 2004; Lee 
et al., 2009). Frequency of depressive episodes and the duration for which depression is 
untreated correlate with magnitude of reduction in hippocampal volume (MacQueen et al., 
2003; Sheline et al., 2003). Reduced hippocampal volume in depression is most likely a result 
of depression rather than a cause. But a smaller hippocampus is thought to be a predisposing 
factor for, rather than a consequence of, post-traumatic stress disorder (Gilbertson et al., 2002). 
Since hippocampus has a critical role in learning and memory, and the prefrontal 
cortex is important for working memory and executive function, the damaging effects of 
stress seen in these regions also affect these functions, in both animals (Sapolsky, 2003) and 
humans (Shors, 2006). Clinical studies have found that depressed patients also often have 
difficulties with concentration and attention, diminished cognitive flexibility, and deficits in 
explicit memory (Austin et al., 2001; Fossati et al., 2001; Fossati et al., 2002; Hammar et al., 
2009). 
Antidepressants protect against hippocampal volume loss in humans (Sheline et al., 
2003) and reverse stress-induced atrophic changes in the hippocampus of animals (Czeh et al., 
2001), thus supporting the hypothesis that the pathophysiology of stress-related disorders such 
as depression involves reductions in neuronal connectivity and that this effect is reversible by 
antidepressant treatment. Results suggest that antidepressant treatment increases synaptic 
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plasticity and connectivity in brain regions associated with mood disorders (Sairanen et al., 
2007). In addition, most antidepressants increase hippocampal neurogenesis, which is also 
required for the behavioural response to antidepressants (Santarelli et al., 2003). 
 
 
1.3.3 The neurotrophic hypothesis of depression 
The damaging effects of stress to the hippocampus and prefrontal cortex can be explained at 
least in part by lack of neurotrophic support. BDNF is the most studied neurotrophic factor in 
this regard. As described previously, BDNF is a member of the neurotrophin family and plays 
an important role in the development and plasticity of the brain by promoting neurogenesis, 
synaptic plasticity and cell survival. Several lines of evidence also points out BDNF to have 
an important role in depression and in mediating the effects of antidepressants. These 
observations have led to the neurotrophic hypothesis of depression, which proposes that 
depression is caused by reduced levels of neurotrophic factors and subsequently decreased 
plasticity in critical neuronal networks, whereas enhancing this neuronal plasticity induces the 
antidepressant effect (Duman, 2004). The neurotrophic factors themselves do not control 
mood, but they act as necessary tools in the activity-dependent modulation of networks 
(Castren et al., 2007). 
BDNF is highly regulated by different stimuli, including stress and antidepressant 
drugs. Both acute and chronic stress, as well as chronic exposure to corticosterone, has been 
shown to decrease BDNF mRNA and protein levels in the hippocampus of rats (Nibuya et al., 
1995; Smith et al., 1995; Schaaf et al., 2000; Gronli et al., 2006; Jacobsen and Mork, 2006) 
and this reduction can be prevented by antidepressant drug treatment (Tsankova et al., 2006). 
Stress-induced downreglation of BDNF-signalling, and neurogenesis, as well as atrophy and 
death of neurons has been suggested to contribute to the reduction in hippocampal volume 
(Sapolsky, 1996; Sheline, 1996; Duman et al., 1999; Sapolsky, 2000). 
Also, levels of brain and serum BDNF has been found to be significantly lower in 
untreated patients with depression compared with treated patients or healthy controls 
(Shimizu et al., 2003; Karege et al., 2005; Monteleone et al., 2008), while the BDNF levels 
are increased in patients receiving antidepressant treatment (Chen et al., 2001; Shimizu et al., 
2003; Huang et al., 2008). As previously described, BDNF is strongly implicated in the 
regulation of hippocampal long-term potentiation (LTP) (Bramham and Messaoudi, 2005). 
Reduced hippocampal BDNF levels have furthermore been shown to impair memory 
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performance in a number of animal studies (Schaaf et al., 2001; Gorski et al., 2003; 
Monteggia et al., 2004). Low plasma BDNF levels have also been associated with memory 
impairment associated with depression (Grassi-Oliveira et al., 2008).  
Interestingly, most antidepressant treatments increase BDNF synthesis and signaling 
in the hippocampus and prefrontal cortex (Castren, 2004; Castren and Rantamaki, 2010). In 
contrast, other classes of psychotrophic drugs, such as opiates or psychostimulants do not 
stimulate BDNF expression in these regions (Chlan-Fourney et al., 2002). Increased BDNF 
signalling in response to chronic antidepressants can reverse the stress-induced reduction of 
hippocampal function and synaptic connections (Nestler et al., 2002; Duman and Monteggia, 
2006). BDNF-mediated signalling appears to be both sufficient and necessary for 
antidepressant action in rodents (Saarelainen et al., 2003). 
 It is thought that induction of BDNF expression in response to chronic antidepressant 
treatment is mediated by the cAMP-CREB pathway (Conti et al., 2002). Repeated, but not 
acute, antidepressant treatment upregulates, via -adrenergic - or 5-HT receptors, the coupling 
of the stimulatory G protein (Gs) to adenylyl cyclase (AC), increases levels of cAMP-
dependent protein kinase (PKA). PKA, Ca2+-dependent protein kinases and also ERK can 
phosphorylate and activate CREB. CREB, which is an transcription factor, regulates 
expression of BDNF. The cAMP-CREB pathway has been found to be upregulated in 
response to antidepressant treatment (Nibuya et al., 1996; Tiraboschi et al., 2004) (Figure 5). 
Further evidence for the neurotrophic hypothesis of depression are displayed through 
several findings which demonstrate signalling pathways involved in BDNF-regulated synaptic 
plasticity to be involved in stress, depression and antidepressant mechanisms. Chronic stress, 
when induced depressive-like behaviour in animal models, has been shown to decrease the 
activity and level of ERK and CREB in the hippocampus and prefrontal cortex (Gronli et al., 
2006; Qi et al., 2008). The depressive-like behaviour and decreased activity of ERK and 
CREB was reversed by fluoxetine treatment (Qi et al.  2008).  
 In rodents, antidepressant effects in two depression models (the learned helplessness 
and forced swim test) have also been observed on direct infusion of BDNF into the 
hippocampus (Shirayama et al., 2002) and midbrain (Siuciak et al., 1997). Such effects were 
blocked on the conditional or inducible knockout of the gene encoding BDNF from forebrain 
regions or with expression of truncated TrkB receptors (Monteggia et al., 2004; Monteggia et 
al., 2007). An opposite role of BDNF is suggested in the ventral tegmental area-nucleus 
accumbens pathway, where over-expression of BDNF or truncated TrkB receptors induces 
depression- or antidepressant-like effects, respectively (Eisch et al., 2003). 
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The neurotrophic hypothesis of depression may explain the delayed clinical response 
to antidepressant drug, as it is thought that a clinical response depend on physical growth and 
reorgnaization in the brain, which are responses that are mediated by BDNF signalling 
(Castren, 2005). However, depression may not be triggered by deficits in BDNF alone, but 
may require impairments in multiple pathways. Elucidation of the molecular mechanisms, 
including signalling pathways and factors regulating gene expression, that underlie the actions 
of stress, depression and antidepressants could reveal targets for the development of novel, 
faster-acting antidepressant agents. 
 
 
 
 
 
 
Figure 5 Regulation of the cAMP-CREB cascade and expression of BDNF by antidepressant treatment  
(From Duman et al., 2002).  
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1.3.4 Sleep in depression 
Sleep disturbances is a common feature in patients with depression (Berger and 
Riemann, 1993), and it has been indicated to be an important aetiological factor in the 
development of the disorder (Lustberg and Reynolds, 2000; Srinivasan et al., 2009). As 
mentioned previously, altered sleep is also a part of the diagnostic criteria for depression. It 
has been suggested that abnormalities of circadian rhythms, which have been described in 
depressed patients might be a precipitating factor in the disorder (Souetre et al., 1989; Avery 
et al., 1999; Bunney and Bunney, 2000). However, the relationship between sleep 
disturbances and depression is not completely understood. 
Up to 90% of depressed patients have complaints of insomnia, which involves 
difficulties in falling asleep, frequent awakenings during the night (sleep fragmentation), and 
early morning awakenings (Cajochen et al., 2000; Almeida and Pfaff, 2005). The internal 
sleep organization is also impaired, with a reduced latency to enter the first REM sleep 
episode, increased total percentage of REM sleep, a reduction of deep SWS (Benca et al., 
1992). Since most antidepressant drugs inhibit REM sleep, it has been suggested that REM 
sleep pressure is enhanced in depressed patients (Vogel et al., 1990). A small group of 
depressed patients (6% to 29 %) show the opposite, having complaints of hypersomnia 
(Roberts et al., 2000). 
Although most depressed patients have disturbed sleep, paradoxically, 50-60 % report 
improved mood following one night of sleep deprivation (Wu and Bunney, 1990; Riemann et 
al., 1999; Giedke and Schwarzler, 2002). The antidepressant effect of sleep deprivation is 
usually only transient, and in most cases relapse occurs after the first episode of recovery 
sleep (Southmayd et al., 1990). Therefore it is rarely used clinically. However, an 
understanding of the neurobiological mechanisms underlying the antidepressant effect of 
sleep deprivation should help to develop new rapidly acting antidepressant strategies. 
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2 Aims
 
Paper I 
To determine whether BDNF regulates intitation and translation factor activity during BDNF-
LTP in vivo and in isolated synapses from the adult dentate gyrus in vitro. 
 
Paper II and III
To determine whether post-transcriptional mechanisms, mediated by translation factor and 
CPEB activity, contribute to the antidepressant (fluoxetine) action. 
 
Paper IV 
To examine the effect of stress and sleep deprivation on post-transcriptional regulation by 
translation factors and CPEB.   
 
 
 
 
 
 
 
3 Methods
 
Detailed explanations of the methods are found in the “Materials and methods” section in the 
attached papers. 
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4 Summary and discussion of results 
4.1 Paper I 
Brain-derived neurotrophic factor (BDNF) is critically involved in long-lasting forms of 
synaptic plasticity which requires new protein synthesis. Previously, we have shown that local 
infusion of BDNF into the dentate gyrus of intact rats triggers LTP (BDNF-LTP), and that 
this depends on new gene expression and protein synthesis (Ying et al., 2002; Messaoudi et 
al., 2002; Messaoudi et al., 2007). Protein synthesis can be regulated at the level of initiation 
and elongation, and two of the key regulators of these events are eIF4E and eEF2. However, 
these two have never been studied together in the context of synaptic plasticity. In this study 
we investigated the regulation of these factors in response to exogenously applied BDNF in 
vivo, and also to isolate the synaptic effects of BDNF application to synapses in vitro.  
LTP was induced in the dentate gyrus of anesthetized rats by local infusion of BDNF. 
The brains were collected at 15 min and 3 h after the end of infusion. CA1, CA3 and dentate 
gyrus were microdissected and homogenized. Western blotting was used to determine 
phosphorylation- and total level of the translation factors eIF4E and eEF2 in the homogenate. 
BDNF-LTP did not induce any significant effects in the CA1 or CA3 regions. In the dentate 
gyrus, there was increased phosphorylation of eIF4E, paralleled by increased levels of total 
eIF4E, 15 min after end of the infusion. At this timepoint there was also an increase in eEF2 
phosphorylation, but total levels of eEF2 were unchanged. 3 h after end of infusion, 
phosphorylation levels of eIF4E and eEF2 and total levels of eIF4E had returned to control. 
The effects of BDNF-LTP on phosphorylation and total levels of eIF4E were confirmed and 
further localized by immunohistochemistry. Enhanced staining was observed in the granule 
cell layer of the BDNF-infused dentate gyrus, compared to the contralateral side. Infusion of 
cytochrome C, which has similar molecular weight and charge as BDNF, had no effect on the 
translation factors. 
Previous studies from our laboratory have reported that BDNF-LTP requires activation 
of the ERK pathway (Ying et al., 2002; Messaoudi et al., 2002). It has also been shown that 
BDNF-induced signalling through this pathway regulates phosphorylation of eIF4E in vitro 
(Takei et al., 2001; Kelleher, III et al., 2004). We therefore examined a possible role of ERK 
activation in regulation of eIF4E and eEF2 during BDNF-LTP. The ERK inhibitor UO126 
blocked BDNF-LTP and the increases in phosphorylation of eIF4E and eEF2 and total eIF4E.  
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Next, we wanted to examine the possibility of spatially different effects of BDNF on 
translation factor regulation. In order to investigate the effect of BDNF in dendritic spines, we 
used a synaptodendrosome (SD) preparation, a subcellular fraction containing pinched-off 
dendrites. SDs were fractionated from dentate gyrus of naïve rats, and treated with BDNF for 
5, 15 and 30 min. After 5 min of BDNF-treatment there was a significant increase in eIF4E-
phosphorylation, but no change in eEF2 phosphorylation. Paralleling this was an enhanced 
expression and phosphorylation of -CaMKII, as well as enhanced expression of total eEF2. 
No significant changes were observed after 15 or 30 min treatment with BDNF.  
Taken together, these findings demonstrate that induction of BDNF-LTP in vivo 
induces a transient phosphorylation of eIF4E and eEF2 that requires ERK signalling.  The 
demonstration of ERK-dependent regulation of translation factor eIF4E and eEF2 during 
BDNF-LTP indicates that ERK has a central role in BDNF-induced synaptic plasticity. A 
coincident increase in phosphorylation of eIF4E and eEF2 indicates enhanced general protein 
synthesis. Phosphorylation of eIF4E at Ser209 is generally associated with increased rates of 
translation (Gingras et al. 2004). This phosphorylation reduces eIF4Es affinity for the 5´ cap, 
which promotes reinitiation on the same mRNA or on another message (Scheper and Proud 
2002). eIF4E is phosphorylated by the mitogen-activated protein kinase-interacting kinase 1 
(Mnk1), which is a substrate of ERK (Wang et al. 1998; Waskiewicz et al. 1999). The ERK 
pathway is required for BDNF-induced enhancement of protein synthesis (Kelleher et al. 
2004). The elongation step is also a target for regulation, which can be mediated by 
phosphorylation of eEF2 (Browne and Proud, 2002). Phosphorylation of eEF2 at Thr56 
inhibits its activity, which thereby leads to decreased elongation and decreased rates of 
general translation (Redpath and Proud, 1993). However, some mRNAs which are critically 
involved in long-lasting synaptic plasticity undergo enhanced translation under conditions of 
eEF2 phosphorylation and decreased general translation (Scheetz et al., 2000; Chotiner et al., 
2003; Belelovsky et al., 2005; Park et al., 2008). When elongation becomes the rate-limiting 
step in translation, it has been suggested that eEF2 phosphorylation may selectively favour 
translation of poor initiators, or inefficiently translated mRNAs, such as Arc and -CaMKII 
(Walden and Thach, 1986; Belelovsky et al., 2005). 
In the present study we observed that in vivo induced BDNF-LTP is associated with a 
transient ERK-dependent phosphorylation of eEF2 in whole dentate gyrus. Surprisingly, 
BDNF stimulation of synaptodendrosomes did not alter eEF2 phosphorylation state, but led to 
increased eIF4E phosphorylation and enhanced ecpression of -CaMKII. Thus, BDNF 
appears to affect translation in a compartment-specific manner, enhancing initiation at 
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synapses while promoting elongation arrest at non-synaptic sites. In contrast, NMDA 
treatment of synaptoneurosomes enhances eEF2 phosphorylation and suppresses general 
protein synthesis while increasing -CaMKII expression (Scheetz et al. 2000). Further work is 
needed to clarify the role of eEF2 phosphorylation in different forms of synaptic 
plasticity.The enhanced expression of -CaMKII following BDNF stimulation of 
synaptodendrosomes, as observed in the present study, can not be due to protein transport, but  
might result from the translation of dendritically localized -CaMKII mRNAs. Previous 
studies have shown that BDNF can regulate the local synthesis of synaptic proteins (Kang and 
Schuman, 1996; Huber et al., 2000; Aakalu et al., 2001; Zhang and Poo, 2002; Yin et al., 
2002). It has been suggested that BDNF regulates local translation through activation of the 
ERK- and PI3K pathways (Schratt et al., 2004). An illustration of neurotransmitter-coupled 
pathways that have been implicated in the control of dendritic protein synthesis is given in 
figure 6.  
 
 
4.2 Paper II and III 
Antidepressant drugs must be taken for several weeks until a therapeutic effect occur, even if 
these drugs raise the monoamine levels in the brain immediately. This suggests that increasing 
monoamine levels is not enough, but that a secondary, delayed response is what eventually 
mediates a mood-enhancing response. Since depression is characterized by impaired neuronal 
plasticity, it is suggested that antidepressants are able to normalize such effects, and that the 
delayed effect of antidepressants reflects the time required to produce neuroadaptive 
mechanisms that may enhance neuronal plasticity (Pittenger and Duman, 2008). 
Characterizing the mechanisms that underlies this delayed response might reveal new targets 
for more fast acting drugs. While most attention has been given to characterize the effects on 
gene transcription, possible effects on post-transcriptional regulation have received almost no 
attention. In paper II and III we investigated the effect of the selective serotonin reuptake 
inhibitor fluoxetine on post-transcriptional regulation. In paper II, the effect on two factors 
critically involved in the regulation of general translation, eIF4E and eEF2, was examined. In 
paper III, we examined the effect of fluoxetine on a RNA-binding protein that serves mRNA 
specific translation, CPEB1. 
Rats received either one injection (acute treatment) or daily injections of fluoxetine for 
21 days, before the dentate gyrus, hippocampus proper and prefrontal cortex were 
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microdissected and further analysed. Western blotting was used to determine the level of 
phosphorylation and total level of eIF4E, eEF2 and CPEB. While acute treatment with 
fluoxetine had no significant effects, chronic treatment induced region-specific changes in 
translation factor and CPEB phosphorylation state. In all three regions, chronic fluoxetine 
induced increased phosphorylation of eEF2 (paper II) and CPEB (paper III), while eIF4E was 
phosphorylated specifically in the dentate gyrus (paper II). In addition, in paper III we 
demonstrated that the increased activity of CPEB was sustained in the hippocampus proper up 
to one week after treatment. Expression of two other CPEB isoforms was also regulated in a 
region-specific manner in response to chronic fluoxetine; in the dentate gyrus, levels of 
CPEB3 were increased, whereas levels of CPEB4 were decreased. Conversely, in the 
prefrontal cortex, levels of CPEB3 were decreased, whereas levels of CPEB4 were increased 
one week after treatment was ended.  
 The impact of enhanced translation factor and CPEB activity in response to fluoxetine 
remains to be determined. Several studies have shown that antidepressant drugs produces 
secondary effects similar to those induced by neuronal plasticity, through increased synthesis 
and signalling of BDNF (Castren et al. 2004). Most antidepressant drugs increases the 
expression of BDNF. BDNF signalling is also suggested to be necessary for the effect of 
antidepressants, as these drugs fail to induce behavioural responses in mice with reduced 
BDNF levels or TrkB signalling (Saarelainen et al. 2003; Monteggia et al. 2004). Previously, 
we have shown that BDNF affects translational regulation through phosphorylation of eIF4E 
and eEF2 in the dentate gyrus, similar to what was seen after chronic fluoxetine. It is therefore 
tempting to consider that BDNF couples antidepressant treatment to enhanced translation 
factor activity. BDNF has been found to regulate translation through activation of the ERK- 
and PI3K-mTORC1 pathways (Schratt et al., 2004; Kelleher, III et al., 2004; Klann et al., 
2004). Enhanced phosphorylation of eEF2 is associated with decreased rates of general 
translation (Redpath and Proud, 1993). In line with that, BDNF-induced dephosphorylation 
has been shown to increase the total rate of protein synthesis in cortical neurons (Inamura et 
al., 2005; Takei et al., 2009). However, other studies have shown that under conditions with 
enhanced eEF2 phosphorylation and decreased rate of general protein synthesis, some specific 
mRNAs undergo enhanced translation (Scheetz et al., 2000; Ying et al., 2002; Chotiner et al., 
2003; Belelovsky et al., 2005; Kanhema et al., 2006). Thereby, increased phosphorylation of 
both eEF2 and eIF4E in response to chronic fluoxetine could favour translation of some 
mRNAs. The identity of these mRNAs and whether their protein products are involved in 
mediating an antidepressant response are issues that need to be addressed.  
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 The enhanced phosphorylation of CPEB after chronic treatment with fluoxetine 
indicates that CPE-containing mRNAs might be involved in the antidepressant action. Many 
of CPEBs potential targets encode proteins that are important in mediating synaptic plasticity. 
Among these are BDNF and tPA, which are also implicated in antidepressant drug action. 
BDNF has been identified as a target as it contains both the CPE and hexanucleotide sequence, 
which are necessary for CPEB-induced polyadenylation. Importantly, no studies have 
demonstrated CPEB-mediated polyadenylation-induced translation of BDNF. tPA has been 
shown to be bound by CPEB and translated in  the synaptic region in response to glutamate, 
dependent on metabotropic glutamate receptor (mGluR) activation (Shin et al., 2004). It 
remains to be examined whether CPEB regulates translation of these mRNAs in response to 
chronic fluoxetine. If so, CPEB might be an important factor linking chronic antidepressant 
treatment to upregulation of BDNF levels and signalling.  
The dentate gyrus seems to have a particularly important role in the action of 
antidepressants. The ability to produce new granule cells throughout life (neurogenesis) is one 
of the unique features of this region. Chronic treatment with fluoxetine and several other 
antidepressant drugs has been shown to increase neurogenesis in the dentate gyrus (Malberg 
et al., 2000; Santarelli et al., 2003; Chen et al., 2006) which is also important for the 
behavioural effect of these drugs (Santarelli et al., 2003). BDNF signalling plays a role in the 
differentiation and survival of the newborn neurons (Lee et al., 2002; Sairanen et al., 2005; 
Bergami et al., 2008). In addition, BDNF specifically in the dentate gyrus (and not CA1) 
might be essential in mediating the therapeutic effect of antidepressants (Adachi et al., 2008). 
In the present study, localization of phosphorylated eIF4E is different after chronic fluoxetine 
treatment compared to what was observed after BDNF-LTP (Kanhema et al. 2006). While 
enhanced p-eIF4E was observed in the granule cell layer in the dentate gyrus after BDNF-
LTP, increased staining was observed specifically in the subgranular zone after chronic 
fluoxetine. As the subgranular zone is where neurogenesis occurs, it might be that the 
increased staining with p-eIF4E was specific to antidepressant-induced new neurons. 
 One side-effect of intraperitoneal fluoxetine injections is skin irritations. This was 
observed in the present study and has also been reported by others (Fisher et al., 1999; 
Perrone et al., 2004). However, injection is a more reliable and controllable form of 
administration than oral delivery, but it is possible that the skin irritation is a confounding 
factor in studies of chronic intraperitoneal administration.  
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4.3 Paper IV 
Chronic stress, which represents an important precipitating factor in depression, has shown to 
induce cellular and structural changes in the brain that might leads to dysfunctional synaptic 
plasticity.  The molecular mechanisms underlying the response to stress are little understood.  
In this study we examined the effects of chronic mild stress (CMS) and sleep 
deprivation (SD) in rats on translational regulation in the prefrontal cortex and hippocampal 
formation, brain regions that are strongly affected by stress (McEwen, 2001; Kim and 
Diamond, 2002; Pittenger and Duman, 2008). Four weeks of CMS treatment induced 
phosphorylation of eIF4E and eEF2 specifically in the prefrontal cortex; translation factor 
activity was unaltered in the hippocampus proper and dentate gyrus.  Next we assessed the 
effects of 8 hours total SD, a treatment linked to rapid and transient relief from depression in 
humans, (Wu and Bunney, 1990). SD was given alone or following CMS (CMS+SD). 
Healthy rats subjected to SD alone exhibited enhanced phosphorylation of eEF2 in all brain 
regions, whereas eIF4E phosphorylation was elevated in prefrontal cortex but decreased in the 
dentate gyrus. When chronically stressed rats were sleep deprived (CMS+SD group), changes 
in translation factor phosphorylation in the dentate gyrus and hippocampus proper were 
similar to those induced by SD alone. No additional changes in eIF4E and eEF2 activity were 
detected in the prefrontal cortex in rats subjected to SD after CMS. CPEB phosphorylation 
state or total CPEB levels were unaffected, except of CPEB dephosphorylation in the 
hippocampus proper after SD. We also examined the expression of genes (Arc and BDNF) 
which are known to be upregulated during long-lasting forms of synaptic plasticity or chronic 
antidepressant treatment (Pei et al., 2003; Wibrand et al., 2006; Alme et al., 2007). In the 
prefrontal cortex, Arc and BDNF mRNA levels were increased following SD of both naïve 
and CMS treated rats.  Levels of plasma corticosterone were elevated in a similar pattern.  In 
the dentate gyrus and hippocampus proper, Arc mRNA levels increased only when treatments 
were combined (CMS+SD), accomponied by a decrease in BDNF mRNA expression in the 
dentate gyrus.   
These findings demonstrate brain region-specific regulation of translation factor and 
CPEB phosphorylation state associated with CMS and with SD in naïve and CMS exposed 
rats. Prefrontal cortex was specifically affected by CMS, which induced increased 
phosphorylation of both eIF4E and eEF2 in this region. This change indicates enhanced 
translation. Phosphorylation of eIF4E is generally correlated with enhanced rates of 
translation (Scheper and Proud 2002; Senthil et al. 2002; Duncan et al. 2003). The 
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phosphorylation event decreases the affinity of eIF4E binding to the cap structure, which may 
promote scanning of the initiation complex to the startsite or facilitate recruitment of new 
complexes (ribosomal loading). Phosphorylation of eEF2 acts to slow the peptide chain 
elongation and inhibit general protein synthesis, while simultaneously promoting the 
translation of mRNAs that are poor initiators, typically mRNAs with extensive secondary 
structure in their 5´ leader sequence (Walden and Tchah 1986; Scheetz et al. 2000; Belelovsky 
et al. 2005). Thus, the parallel increase in eEF2 and eIF4E phosphorylation in the prefrontal 
cortex indicate enhanced translation in response to chronic stress. SD of naïve rats induced the 
same pattern of translation factor activity in the prefrontal cortex. This may indicate that 
prefrontal cortex is generally more sensitive to both acute and chronic stress, and the possible 
enhancement of translation may constitute a compensatory mechanism to the stress. In the 
dentate gyrus and hippocampus proper, translational control is selectively modulated by SD, 
and not affected by chronic stress. The dephosphorylation of eIF4E combined with enhanced 
phosphorylation of eEF2 in the dentate gyrus constitutes a double mechanism for decreasing 
overall protein synthesis. In the hippocampus proper, CPEB was dephosphorylated in 
response to SD in naïve rats, paralleled by increased eEF2 phosphorylation, which may 
indicate that sleep deprivation inhibits general protein synthesis in this region through 
decreasing elongation rate, as well as decreasing polyadenylation-dependent translation. 
Based on these findings we suggest that sleep deprivation selectively favours translation of 
certain mRNAs in the prefrontal cortex, while decreasing the capacity of general protein 
synthesis in the hippocampal formation. However, use of 2D gels and proteomic methods are 
needed to verify effects on protein synthesis. 
When rats were exposed to sleep deprivation following CMS exposure, the responses 
in translation factor activity in the hippocampal formation were similar to those observed 
following sleep deprivation alone. This could indicate that this region is sensitive to sleep 
loss per se. However, the dephosphorylation of eIF4E in the dentate gyrus correlated with 
corticosterone levels, which indicate that at least this change was a response to stress. Since 
no change was observed following CMS, the hippocampal formation might have adapted to 
this prolonged stress. This is in contrast to prefrontal cortex, were similar responses in 
translation factor activity were observed following both CMS and sleep deprivation. 
Surprisingly, when sleep deprivation was given following CMS exposure, no additional 
response in translation factor activity was observed in the prefrontal cortex. This may 
indicate that chronic stress triggers a maximum translational response (a ceiling effect) in the 
prefrontal cortex that is not further enhanced by SD.  
 37
 In this study we used a rat model for chronic stress based on subjecting rats to daily 
hassles. Exposure to the CMS protocol has been established and validated as an animal 
model of depression in our laboratory with e.g. less consumption of sucrose (anhedonic 
response) and sleep alterations (Gronli et al., 2004; Gronli et al., 2005). In the present study, 
rats exposed to CMS reduced their bodyweight, and showed sleep alterations typically 
observed in depressed patients (e.g. fragmented sleep, less deep sleep). However, no 
anhedonic behaviour (less preference for sucrose) in rats exposed to CMS was observed, 
mostly due to a high inter-individual variability. In addition, housing conditions might also 
be a factor that influenced the outcome. All rats were single-housed in individually ventilated 
cages, and could not smell each other. It has been demonstrated that isolated rats (single-
housed) show a significant reduction in BDNF protein concentrations in the hippocampus 
compared to rats housed two per cage, and the authors suggested social isolation as a model 
for the study of antidepressant treatments (Scaccianoce et al., 2006).  
 CMS induced few changes in translation factor activity and mRNA expression. When 
these rats were exposed to sleep deprivation they had larger responses in eEF2 
phosohorylation, although not significantly larger compared to sleep deprived naïve rats. 
However, a striking difference in mRNA expression was observed between CMS and naïve 
rats that were sleep deprived; Arc mRNA was upregulated in the dentate gyrus and 
hippocampus proper only after sleep deprivation of CMS rats, not after sleep deprivation of 
naive rats or after CMS alone. This effect was most prominent in the dentate gyrus, as there 
was a trend of increased Arc mRNA in the hippocampus proper following sleep deprivation 
alone. Another mRNA, TGF -beta-induced immediate early gene-1 (TIEG1), was also 
upregulated in a similar manner as Arc mRNA in both these regions (data not shown), 
significantly increased expression following sleep deprivation of CMS rats only. Coincident 
upregulation of Arc and TIEG1 mRNA has previously been shown in the dentate gyrus in 
response to both BDNF-LTP and HFS-LTP (Wibrand et al., 2006) and in the hippocampus 
proper in response to chronic, but not acute, treatment with the SSRI fluoxetine (Alme et al., 
2006).  
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Figure 6 Illistration of neurotransmitter-coupled pathways that have been implicated in the control of protein 
synthesis at excitatory synapses in the mammalian brain (From Bramham and Wells, 2007). 
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5 Conclusions and future perspectives 
Stress can induce molecular and cellular changes in the brain, and when stress is prolonged 
these changes may lead to dysfunctional synaptic plasticity. This is suggested to be a risk 
factor in the development of depression. Chronic treatment with antidepressant drugs is 
suggested to enhance synaptic plasticity, and thereby oppose the damaging effects of stress. 
The molecular mechanisms for how stress and antidepressants influence synaptic plasticity 
are not fully understood. Long-lasting synaptic plasticity is dependent on new protein 
synthesis, and regulation of translation plays a key role in regulation of synaptic plasticity.   
In the present studies we examined the translational regulating mechanisms involved 
in a long-lasting form of synaptic plasticity, in response to acute and chronic antidepressant 
drug treatment, and in response to chronic stress and sleep deprivation, the latter which can 
act as an acute stressor, but which also has been shown to induce a rapid antidepressant effect.  
In paper I we show that BDNF, when exogenously applied to induce LTP in the 
dentate gyrus, exerts rapid and transient modulation of both initiation and elongation as a 
general effect. This regulation is dependent on ERK signalling. BDNF-mediated regulation of 
translation is compartment-specific, as BDNF appears to selectively facilitate initiation at 
synapses. In paper II we show that chronic, but not acute, treatment with the antidepressant 
fluoxetine induces region-specific regulation of translation factor activity. In the dentate gyrus, 
regulation of initiation and elongation was similar to what we observed in response to BDNF-
induced LTP in paper I. In paper III we demonstrate that chronic fluoxetine also affects other 
mechanisms of translational regulation, through phosphorylation of the RNA binding protein 
CPEB. From paper II and III we suggest that post-transcriptional regulation contributes to the 
delayed effects of antidepressant drugs. In paper IV we show that chronic stress affects 
translational regulation specifically in the prefrontal cortex, while having no effects in the 
hippocampus proper and dentate gyrus. Sleep deprivation has a more widespread effect on 
translational regulation; while elongation was similarly regulated in all regions, initiation was 
regulated in a region-specific manner.  
Taken together, this work identifies translation as a common control point in the 
context of synaptic plasticity, stress, and antidepressant drug actions. This is important  
because it implies that stress mechanisms, like memory, may involve rapid  
synapse-specific control of protein synthesis. The functional impact of translational regulation 
associated with synaptic plasticity, stress and antidepressant treatment has to be elucidated. 
Identifying the subpopulations of mRNAs that are regulated, their localization, and the time-
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course of the effects are the first steps to take. Ultimately, this could pave the way for the 
development of better antidepressants and cognition-enhancing drugs. 
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